Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability.
about
Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Gemcitabine and Oxaliplatin, b ...... carcinoma Cell Line Viability.
@en
type
label
Gemcitabine and Oxaliplatin, b ...... carcinoma Cell Line Viability.
@en
prefLabel
Gemcitabine and Oxaliplatin, b ...... carcinoma Cell Line Viability.
@en
P2093
P1476
Gemcitabine and Oxaliplatin, b ...... carcinoma Cell Line Viability.
@en
P2093
Bruno Clément
Cédric Coulouarn
Etienne Garin
Laurence Crouzet
Marc Pracht
P304
1874-78.e2
P356
10.1016/J.JVIR.2015.06.032
P577
2015-12-01T00:00:00Z